TUESDAY, Oct. 17, 2017 -- Machines armed with artificial intelligence may one day help doctors better identify high-risk breast lesions that might turn into cancer, new research suggests.
High-risk breast lesions are abnormal cells found in a breast biopsy. These lesions pose a challenge to doctors and patients. The cells in such lesions aren't normal, but they're not cancerous either. And although they can develop into cancer, many don't. So, which ones need to be removed?
TUESDAY, Oct. 3, 2017 -- New research finds the number of American women who've lost their lives to breast cancer has fallen precipitously in the past 25 years, with more than 322,000 lives saved in that time.
Overall, advances in care have led to a 39 percent drop in breast cancer deaths of between 1989 and 2015, according to new research from the American Cancer Society (ACS).
WEDNESDAY, Sept. 13, 2017 -- A breast cancer patient's choice of surgeon can have a major effect on her treatment, according to a new study.
That's because surgeons have a strong influence on whether early stage cancer patients have both breasts removed even when cancer is found in only one breast -- a procedure called contralateral prophylactic mastectomy (CPM).
MONDAY, Sept. 11, 2017 -- Breast cancer patients who take opioid painkillers are more likely to discontinue an important hormone treatment that helps ensure their survival, researchers report.
Use of prescription opioids such as OxyContin (oxycodone) and Vicoprofen (hydrocodone) was "significantly associated" with failure to adhere to the hormone therapy and a higher risk of death, the study found.